Imricor Medical Systems, Inc. (IMR.AX)
AUD 0.96
(-2.05%)
AUD 0.96
(-2.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -17.57 Million AUD | -47.82% |
| 2022 | -17.17 Million USD | 12.46% |
| 2021 | -19.62 Million AUD | -68.91% |
| 2020 | -11.61 Million AUD | 3.23% |
| 2019 | -12 Million AUD | -86.09% |
| 2018 | -6.45 Million AUD | 1.41% |
| 2017 | -6.54 Million AUD | -20.07% |
| 2016 | -5.44 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.03 Million USD | -4.24% |
| 2024 Q2 | -4.03 Million USD | 0.0% |
| 2023 Q1 | -4.56 Million USD | -20.79% |
| 2023 FY | -25.39 Million AUD | -47.82% |
| 2023 Q4 | -3.86 Million USD | 0.0% |
| 2023 Q3 | -3.86 Million USD | 15.21% |
| 2023 Q2 | -4.56 Million USD | 0.0% |
| 2022 FY | -17.17 Million USD | 12.46% |
| 2022 Q3 | -3.77 Million USD | 22.23% |
| 2022 Q2 | -4.85 Million USD | 0.0% |
| 2022 Q1 | -4.85 Million USD | 7.59% |
| 2022 Q4 | -3.77 Million USD | 0.0% |
| 2021 Q3 | -5.25 Million USD | -7.74% |
| 2021 Q4 | -5.25 Million USD | 0.0% |
| 2021 Q2 | -4.87 Million USD | 0.0% |
| 2021 FY | -19.62 Million AUD | -68.91% |
| 2021 Q1 | -4.87 Million USD | -47.89% |
| 2020 Q1 | -2.68 Million USD | -51.84% |
| 2020 Q3 | -3.29 Million USD | -22.99% |
| 2020 Q2 | -2.68 Million USD | 0.0% |
| 2020 Q4 | -3.29 Million USD | 0.0% |
| 2020 FY | -11.61 Million AUD | 3.23% |
| 2019 Q1 | -1.5 Million USD | -16.16% |
| 2019 FY | -12 Million AUD | -86.09% |
| 2019 Q4 | -1.76 Million USD | 0.0% |
| 2019 Q3 | -1.76 Million USD | -17.08% |
| 2019 Q2 | -1.5 Million USD | 0.0% |
| 2018 Q3 | -1.29 Million USD | -16.92% |
| 2018 Q1 | -1.11 Million USD | 0.0% |
| 2018 Q2 | -1.11 Million USD | 0.0% |
| 2018 Q4 | -1.29 Million USD | 0.0% |
| 2018 FY | -6.45 Million AUD | 1.41% |
| 2017 FY | -6.54 Million AUD | -20.07% |
| 2016 FY | -5.44 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 37.155% |
| Adherium Limited | -11.98 Million AUD | -46.641% |
| Aroa Biosurgery Limited | -9.78 Million AUD | -79.566% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -302.968% |
| Anteris Technologies Ltd | -66.63 Million AUD | 73.624% |
| Control Bionics Limited | -5.92 Million AUD | -196.417% |
| CardieX Limited | -4.63 Million AUD | -279.293% |
| Compumedics Limited | -269 Thousand AUD | -6433.586% |
| Cochlear Limited | 521.5 Million AUD | 103.37% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -265.091% |
| Cyclopharm Limited | -9.22 Million AUD | -90.525% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -988.655% |
| Nova Eye Medical Limited | -3.79 Million AUD | -362.875% |
| HeraMED Limited | -6.42 Million AUD | -173.419% |
| ImpediMed Limited | -19.03 Million AUD | 7.673% |
| InhaleRx Limited | -1.38 Million AUD | -1167.617% |
| LBT Innovations Limited | -4.74 Million AUD | -270.788% |
| Micro-X Limited | -13.02 Million AUD | -34.915% |
| Neurotech International Limited | -5.58 Million AUD | -214.7% |
| OncoSil Medical Limited | -11.98 Million AUD | -46.654% |
| PolyNovo Limited | 1.16 Million AUD | 1611.208% |
| Respiri Limited | -7 Million AUD | -151.069% |
| SomnoMed Limited | -3.84 Million AUD | -357.537% |
| Universal Biosensors, Inc. | -16.68 Million AUD | -5.366% |
| Uscom Limited | -2.4 Million AUD | -630.981% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -200.221% |